87 related articles for article (PubMed ID: 29067458)
1. Associations between mutations of the cell cycle checkpoint kinase 2 gene and gastric carcinogenesis.
Hong Y; Shi J; Ge Z; Wu H
Mol Med Rep; 2017 Oct; 16(4):4287-4292. PubMed ID: 29067458
[TBL] [Abstract][Full Text] [Related]
2. The risk of gastric cancer in carriers of CHEK2 mutations.
Teodorczyk U; Cybulski C; Wokołorczyk D; Jakubowska A; Starzyńska T; Lawniczak M; Domagała P; Ferenc K; Marlicz K; Banaszkiewicz Z; Wiśniowski R; Narod SA; Lubiński J
Fam Cancer; 2013 Sep; 12(3):473-8. PubMed ID: 23296741
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma.
Okamoto T; Kohno M; Ito K; Takada K; Katsura M; Morodomi Y; Toyokawa G; Shoji F; Maehara Y
Anticancer Res; 2017 Apr; 37(4):1729-1735. PubMed ID: 28373435
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of CHEK2 Mutation in Progression of Breast Cancer.
Ansari N; Shahrabi S; Khosravi A; Shirzad R; Rezaeean H
Lab Med; 2019 Jul; 50(3):e36-e41. PubMed ID: 31220302
[TBL] [Abstract][Full Text] [Related]
5. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.
Al-Rakan MA; Hendrayani SF; Aboussekhra A
BMC Cancer; 2016 Aug; 16():575. PubMed ID: 27484185
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
[TBL] [Abstract][Full Text] [Related]
7. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
Wei B; Huang QY; Huang SR; Mai W; Zhong XG
Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
[TBL] [Abstract][Full Text] [Related]
9. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
[TBL] [Abstract][Full Text] [Related]
10. DC - SIGNR by influencing the lncRNA HNRNPKP2 upregulates the expression of CXCR4 in gastric cancer liver metastasis.
Zhang Y; Zhang Q; Zhang M; Yuan M; Wang Z; Zhang J; Zhou X; Zhang Y; Lin F; Na H; Ren S; Zuo Y
Mol Cancer; 2017 Apr; 16(1):78. PubMed ID: 28403883
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
12. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
13. Inverse association between miR-194 expression and tumor invasion in gastric cancer.
Song Y; Zhao F; Wang Z; Liu Z; Chiang Y; Xu Y; Gao P; Xu H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S509-17. PubMed ID: 21845495
[TBL] [Abstract][Full Text] [Related]
14. The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study.
Alorjani M; Aburub M; Al-Trad B; Hamad MA; AbuAlarja M; Bashir SA; Al-Batayneh K; Zoubi MA
Med Arch; 2023 Feb; 77(1):8-12. PubMed ID: 36919124
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
16. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑21 expression is associated with the clinical features of patients with gastric carcinoma and affects the proliferation, invasion and migration of gastric cancer cells by regulating Noxa.
Sun H; Wang P; Zhang Q; He X; Zai G; Wang X; Ma M; Sun X
Mol Med Rep; 2016 Mar; 13(3):2701-7. PubMed ID: 26847916
[TBL] [Abstract][Full Text] [Related]
18. Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study.
Näslund-Koch C; Nordestgaard BG; Bojesen SE
J Clin Oncol; 2016 Apr; 34(11):1208-16. PubMed ID: 26884562
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
20. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
